Zydus Pharmaceuticals (USA) Colchicine Tablets, USP 0.6 mg recall — FDA D-0467-2023
Failed Impurities/Degradation Specifications: An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine.